XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Millions
9 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:    
Net income $ 1,305 $ 1,070
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 123 105
Deferred income taxes, net (22) 23
Premium and discount amortization on available-for-sale securities and bank loans and net unrealized gain/loss on other investments (37) 40
Provisions for credit losses and legal and regulatory proceedings 191 72
Share-based compensation expense 192 149
Unrealized (gain)/loss on company-owned life insurance policies, net of expenses (125) 136
Other (1) 25
Net change in:    
Assets segregated for regulatory purposes excluding cash and cash equivalents 0 101
Collateralized agreements, net of collateralized financings 9 10
Loans (provided to) financial advisors, net of repayments 16 (85)
Brokerage client receivables and other receivables, net 456 (57)
Trading instruments, net 62 126
Derivative instruments, net (224) 246
Other assets (43) (97)
Brokerage client payables and other payables (5,764) 2,985
Accrued compensation, commissions and benefits (95) (261)
Purchases and originations of loans held for sale, net of proceeds from sales of securitizations and loans held for sale 9 (18)
Net cash provided by/(used in) operating activities (3,948) 4,570
Cash flows from investing activities:    
Increase in bank loans, net (762) (5,377)
Proceeds from sales of loans held for investment 600 191
Purchases of available-for-sale securities (561) (2,743)
Available-for-sale securities maturations, repayments and redemptions 977 1,346
Proceeds from sales of available-for-sale securities 0 2
Cash and cash equivalents acquired in business acquisitions, including those segregated for regulatory purposes, net of cash paid for acquisitions 0 1,769
Additions to property and equipment (122) (68)
Sales of Federal Home Loan Bank stock, net 3 0
Investment in note receivable 0 (125)
Purchases of other investments, net (6) (33)
Other investing activities, net (61) (81)
Net cash provided by/(used in) investing activities 68 (5,119)
Cash flows from financing activities:    
Increase in bank deposits 2,411 4,800
Repurchases of common stock and share-based awards withheld for payment of withholding tax requirements (860) (160)
Dividends on preferred and common stock (266) (200)
Exercise of stock options and employee stock purchases 37 44
Redemption of preferred stock (40) 0
Proceeds from Federal Home Loan Bank advances 2,550 1,025
Repayments of Federal Home Loan Bank advances and other borrowed funds (2,741) (906)
Other financing, net (2) (5)
Net cash provided by financing activities 1,089 4,598
Currency adjustment:    
Effect of exchange rate changes on cash and cash equivalents, including those segregated for regulatory purposes 346 (289)
Net increase/(decrease) in cash and cash equivalents, including those segregated for regulatory purposes and restricted cash (2,445) 3,760
Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at beginning of year 14,659 16,449
Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at end of period 12,214 20,209
Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash    
Cash and cash equivalents 8,375 5,958
Cash and cash equivalents segregated for regulatory purposes and restricted cash 3,839 14,251
Total cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at end of period 12,214 20,209
Supplemental disclosures of cash flow information:    
Cash paid for interest 858 137
Cash paid for income taxes, net 536 386
Cash outflows for lease liabilities 92 80
Non-cash right-of-use assets recorded for new and modified leases 112 39
Restricted stock awards issued as consideration for TriState Capital acquisition 0 28
Effective settlement of note receivable for TriState Capital acquisition 0 123
Common stock, par value $.01 per share    
Supplemental disclosures of cash flow information:    
Stock issued for acquisition 0 778
Preferred Stock    
Supplemental disclosures of cash flow information:    
Stock issued for acquisition $ 0 $ 120